Elucidating the specific pharmacological system of action (MOA) of naturally occurring compounds could be complicated. Whilst Tarselli et al. (60) designed the main de novo synthetic pathway to conolidine and showcased this naturally happening compound correctly suppresses responses to both chemically induced and inflammation-derived pain, the pharmacologic focus on https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers